Marcos Navares‐Gómez

967 total citations
35 papers, 361 citations indexed

About

Marcos Navares‐Gómez is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Marcos Navares‐Gómez has authored 35 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 14 papers in Pediatrics, Perinatology and Child Health and 10 papers in Oncology. Recurrent topics in Marcos Navares‐Gómez's work include Pharmacogenetics and Drug Metabolism (20 papers), Drug Transport and Resistance Mechanisms (9 papers) and Pharmaceutical studies and practices (8 papers). Marcos Navares‐Gómez is often cited by papers focused on Pharmacogenetics and Drug Metabolism (20 papers), Drug Transport and Resistance Mechanisms (9 papers) and Pharmaceutical studies and practices (8 papers). Marcos Navares‐Gómez collaborates with scholars based in Spain, United States and Tunisia. Marcos Navares‐Gómez's co-authors include Pablo Zubiaur, Francisco Abad‐Santos, Gina Mejía‐Abril, Dolores Ochoa, Manuel Román, Miriam Saiz‐Rodríguez, Dóra Koller, Alberto M. Borobia, Samuel Martín‐Vílchez and María Santos and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Clinical Pharmacokinetics.

In The Last Decade

Marcos Navares‐Gómez

33 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcos Navares‐Gómez Spain 12 171 73 64 60 53 35 361
K‐S Yu South Korea 10 112 0.7× 89 1.2× 66 1.0× 94 1.6× 57 1.1× 14 376
Humberto Fariñas Spain 10 217 1.3× 67 0.9× 81 1.3× 44 0.7× 46 0.9× 17 345
María Talegón Spain 15 126 0.7× 48 0.7× 76 1.2× 31 0.5× 32 0.6× 17 408
Fernanda Rodrigues‐Soares Brazil 12 307 1.8× 97 1.3× 113 1.8× 89 1.5× 35 0.7× 32 527
Hannah Britz Germany 8 170 1.0× 67 0.9× 104 1.6× 54 0.9× 23 0.4× 8 348
Ingrid Fricke-Galindo Mexico 14 181 1.1× 145 2.0× 130 2.0× 119 2.0× 98 1.8× 41 720
Monpat Chamnanphon Thailand 16 220 1.3× 112 1.5× 133 2.1× 108 1.8× 128 2.4× 36 522
Jacqueline Marti-Jaun Switzerland 10 198 1.2× 41 0.6× 92 1.4× 128 2.1× 34 0.6× 15 463
Martijn L. Manson Sweden 10 113 0.7× 44 0.6× 50 0.8× 111 1.9× 22 0.4× 18 659
Bani Tamraz United States 10 91 0.5× 47 0.6× 49 0.8× 36 0.6× 19 0.4× 20 345

Countries citing papers authored by Marcos Navares‐Gómez

Since Specialization
Citations

This map shows the geographic impact of Marcos Navares‐Gómez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcos Navares‐Gómez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcos Navares‐Gómez more than expected).

Fields of papers citing papers by Marcos Navares‐Gómez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcos Navares‐Gómez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcos Navares‐Gómez. The network helps show where Marcos Navares‐Gómez may publish in the future.

Co-authorship network of co-authors of Marcos Navares‐Gómez

This figure shows the co-authorship network connecting the top 25 collaborators of Marcos Navares‐Gómez. A scholar is included among the top collaborators of Marcos Navares‐Gómez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcos Navares‐Gómez. Marcos Navares‐Gómez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Navares‐Gómez, Marcos, Manuel Román, Gina Mejía‐Abril, et al.. (2025). Impact of Genetic Variants on Pregabalin Pharmacokinetics and Safety. Pharmaceuticals. 18(2). 151–151. 1 indexed citations
2.
Zubiaur, Pablo, et al.. (2024). SLCO1B1 and ABCG2 genotype‐informed phenotypes are related to variation in ramipril exposure. Basic & Clinical Pharmacology & Toxicology. 135(3). 295–307. 1 indexed citations
3.
Navares‐Gómez, Marcos, Francisca Molina‐Jiménez, Emilio J. Laserna‐Mendieta, et al.. (2024). Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis. International Journal of Molecular Sciences. 25(7). 3685–3685. 4 indexed citations
4.
Román, Manuel, Samuel Martín‐Vílchez, Marcos Navares‐Gómez, et al.. (2024). Genetic variation in UGT1A1 is not associated with altered liver biochemical parameters in healthy volunteers participating in bioequivalence trials. Frontiers in Pharmacology. 15. 1389968–1389968. 1 indexed citations
5.
Zubiaur, Pablo, Miriam Saiz‐Rodríguez, Marcos Navares‐Gómez, et al.. (2023). Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post‐surgical pain. Clinical and Translational Science. 17(1). e13698–e13698.
6.
Saiz‐Rodríguez, Miriam, Dolores Ochoa, Pablo Zubiaur, et al.. (2023). Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of Personalized Medicine. 13(3). 489–489. 9 indexed citations
7.
Zubiaur, Pablo, Marcos Navares‐Gómez, Gina Mejía‐Abril, et al.. (2023). Impact of Sex and Genetic Variation in Relevant Pharmacogenes on the Pharmacokinetics and Safety of Valsartan, Olmesartan and Hydrochlorothiazide. International Journal of Molecular Sciences. 24(20). 15265–15265. 1 indexed citations
8.
Zubiaur, Pablo, Dolores Ochoa, Manuel Román, et al.. (2023). Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics. 15(2). 404–404. 7 indexed citations
9.
Zubiaur, Pablo, Marcos Navares‐Gómez, Gina Mejía‐Abril, et al.. (2023). NAT2 phenotype alters pharmacokinetics of rivaroxaban in healthy volunteers. Biomedicine & Pharmacotherapy. 165. 115058–115058. 5 indexed citations
10.
Zubiaur, Pablo, Marcos Navares‐Gómez, Gina Mejía‐Abril, et al.. (2023). Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride. Journal of Personalized Medicine. 13(11). 1566–1566. 1 indexed citations
11.
Zubiaur, Pablo, et al.. (2022). Patients’ Perceptions of Pharmacogenetic Testing and Access to Their Results: State of the Art in Spain and Systematic Review. Journal of Personalized Medicine. 12(2). 270–270. 4 indexed citations
12.
Mejía‐Abril, Gina, Pablo Zubiaur, Marcos Navares‐Gómez, et al.. (2021). Dexketoprofen Pharmacokinetics is not Significantly Altered by Genetic Polymorphism. Frontiers in Pharmacology. 12. 660639–660639. 5 indexed citations
13.
Zubiaur, Pablo, Marcos Navares‐Gómez, Miriam Saiz‐Rodríguez, et al.. (2021). Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin. Frontiers in Pharmacology. 12. 718281–718281. 6 indexed citations
14.
Zubiaur, Pablo, Marcos Navares‐Gómez, Manuel Román, et al.. (2021). Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics. Pharmaceutics. 13(10). 1573–1573. 5 indexed citations
15.
16.
Koller, Dóra, Gina Mejía‐Abril, Miriam Saiz‐Rodríguez, et al.. (2020). Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics. Advances in Therapy. 38(2). 1035–1054. 22 indexed citations
17.
Zubiaur, Pablo, Dóra Koller, Marcos Navares‐Gómez, et al.. (2020). Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers. Biomedicine & Pharmacotherapy. 133. 111087–111087. 16 indexed citations
18.
Saiz‐Rodríguez, Miriam, Marcos Navares‐Gómez, Dolores Ochoa, et al.. (2020). Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates. Biomedicines. 8(4). 94–94. 82 indexed citations
19.
Zubiaur, Pablo, Miriam Saiz‐Rodríguez, Dolores Ochoa, et al.. (2020). Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran. Advances in Therapy. 37(8). 3537–3550. 18 indexed citations
20.
Koller, Dóra, Miriam Saiz‐Rodríguez, Pablo Zubiaur, et al.. (2020). The effects of aripiprazole and olanzapine on pupillary light reflex and its relationship with pharmacogenetics in a randomized multiple‐dose trial. British Journal of Clinical Pharmacology. 86(10). 2051–2062. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K‐S Yu Breakdown of academic impact, for papers by Humberto Fariñas Breakdown of academic impact, for papers by María Talegón Breakdown of academic impact, for papers by Fernanda Rodrigues‐Soares Breakdown of academic impact, for papers by Hannah Britz Breakdown of academic impact, for papers by Ingrid Fricke-Galindo Breakdown of academic impact, for papers by Monpat Chamnanphon Breakdown of academic impact, for papers by Jacqueline Marti-Jaun Breakdown of academic impact, for papers by Martijn L. Manson Breakdown of academic impact, for papers by Bani Tamraz
Rankless by CCL
2026